Nov 17, 2016 09:00AM PDL BioPharma Prices Public Offering of $150.0 Million of 2.75% Convertible Senior Notes Due 2021

Nov 15, 2016 05:46PM PDL BioPharma (PDLI) to Offer $150M in Convertible Senior Notes

Nov 15, 2016 04:48PM PDL BioPharma Announces Proposed $150 Million Public Offering of New Convertible Senior Notes Due 2021

Feb 17, 2016 07:00AM PDL BioPharma to Present at the 2016 RBC Capital Markets' Healthcare Conference

Feb 2, 2016 09:26AM Pre-Open Stock Movers 02/02: (HNSN) (KORS) (GOOGL) (GOOG) Higher; (ZINC) (IDTI) (HEAR) Lower (more...)

Feb 1, 2016 05:41PM After-Hours Stock Movers 02/01: (MAT) (PVH) (GOOGL) Higher; (IDTI) (PDLI) (RCII) Lower (more...)

Sep 21, 2015 11:14AM AcelRx Pharma (ACRX) Strengthens Cash Position for Regulatory with Zalviso Monetization - RBC Capital

Feb 5, 2014 05:08PM PDL BioPharma (PDLI) to Offer $250M in Conv Notes

Oct 11, 2011 10:40AM Notable Analyst Rating Changes 10/11: (NUE) (SFD) (ARO) Upgraded; (COP) (PDLI) (STP) Downgraded

Oct 11, 2011 07:40AM RBC Capital Downgrades PDL BioPharma (PDLI) to Sector Perform, Maintains Price Target

Feb 28, 2011 12:45PM Unusual 11 Mid-Day Movers 02/28: (INV) (DPTR) (MRX) Higher; (CPF) (ALAN) (TLR) Lower

Feb 28, 2011 10:13AM Morning Movers 02/28: (MRX) (PSTR) (BDLI) (OSTK) Higher; (CPF) (KCP) (TLR) Lower

Sep 10, 2010 08:10AM RBC Capital Initiates Coverage on PDL BioPharma (PDLI) with a Sector Perform